NPPES file of Aug 9, 2026

Parmatma Greeley, MD

Endocrinology, Diabetes & Metabolism Physician · Doylestown, PA

Parmatma Greeley, MD is an endocrinology, diabetes & metabolism physician with a practice address in Doylestown, Pennsylvania, and NPI 1457564445, issued on May 7, 2007. Check the license (Pennsylvania MD430764, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1457564445
Name
Parmatma Greeley
Credential
MD
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
MD430764 PA
Self-reported in NPPES; status is on the state search
Practice location
103 Progress Dr, Doylestown, PA 18901
Phone
(215) 447-3630
Enumerated
May 7, 2007
Record last updated
Oct 22, 2019 (not updated in 7 years: call before relying on the address or phone)
Medicare enrollment
Enrolled (PECOS I20070613000440); accepts Medicare assignment
Medical or professional school
University Of Pittsburgh School Of Medicine, 2002
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 103 Progress Dr

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Laura Fitzpatrick, M.D.Endocrinology, Diabetes & Metabolism Physician1245270297
  2. Julie Roper, M.A.,CCC-AAudiologist1154511368
  3. Donald Rudolf, D.M.D.Oral and Maxillofacial Surgery (Dentist)1023072576

Verify Parmatma Greeley in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
    Search for license MD430764
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Pennsylvania license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

97% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

5,183 Medicare Part D claims for 685 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 48% of claims.

  1. Parmatma Greeley5,183
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium620 claims
  2. Synthroid420 claims
  3. Mounjaro351 claims
  4. Ozempic263 claims
  5. Metformin Hcl252 claims
  6. Jardiance225 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 64.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score43.2
  2. Costout of 100 · 30%56.5
  3. Promoting interoperabilitynot scored (reweighted)
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $412.65

25 payments; by number, the most common kind was food and beverage; the largest payer was Abbott Laboratories. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Parmatma Greeley$412.65
  2. Specialty average$5,742.15

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Doylestown Thyroid And Endocrine Associates, LLCDoylestown, PA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Parmatma Greeley among 485 endocrinology, diabetes & metabolism physician records in Pennsylvania

Parmatma Greeley, MD is one of 485 endocrinology, diabetes & metabolism physician records with a practice address in Pennsylvania. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 41% of them.

  • NPI issued2007 · 41% of these records are older, 45% newer
  • In a Medicare fileYes · 84% of these records are
  • In the CMS Doctors and Clinicians fileYes · 69% of these records are
  • Graduated2002 · median 2004 among the 334 with a school on file
  • Record last updated2019 · 62% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Pennsylvania

There are 485 endocrinology, diabetes & metabolism physician records in Pennsylvania.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Laura Fitzpatrick, M.D.Doylestown, PA 189011245270297
  2. Luis Arzeno Tejada, M.D.Doylestown, PA 189021114311347
  3. Brian Beluch, D.O.Doylestown, PA 189021811142508
  4. Jonathan Slusser, DODoylestown, PA 189021750644704
  5. Peter Ucciferro, DODoylestown, PA 189021033572318
  6. Alan Salzman, M.D.New Hope, PA 189381093995326
  7. Shreya Amin, M.D.Quakertown, PA 189511407388671
  8. Diane Schmidt, MDQuakertown, PA 189511124028212

Common questions

What is Parmatma Greeley, MD's NPI number?

Parmatma Greeley, MD's National Provider Identifier (NPI) is 1457564445, issued on May 7, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Parmatma Greeley, MD located?

The NPPES record lists a practice address at 103 Progress Dr, Doylestown, PA, 18901. Phone: (215) 447-3630. Providers update this record themselves, so call before visiting.

How can I verify Parmatma Greeley, MD's license?

NPPES lists Pennsylvania license number MD430764, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Parmatma Greeley, MD prescribe under Medicare Part D?

In 2024, Parmatma Greeley, MD had 5,183 Medicare Part D claims for 685 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Parmatma Greeley, MD's MIPS final score?

The 2023 MIPS final score is 64.2 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.